In this study, we showed that cultured IDH1mut glioma cells are more sensitive than IDH1/2wt cells to the FDA-approved pan-HDACi, panobinostat, and that this is mediated through both cytotoxic and cytostatic effects (Figs. 2 and 3). The gene discussed is IDH1; the disease is central nervous system cancer.